Phase 1 clinical trial for therapeutic intervention particles (tips).

Ended Project Grant Awarded Last action

Award ID
W81XWH2110875
Recipient
Awarding agency
Obligated
$4,499,999

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
San Francisco, CA 94158, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment Phase 1 clinical trial for therapeutic intervention particles $0
Amendment Phase 1 clinical trial for therapeutic intervention particles transfer award from j. David gladstone institutes to institute for evolvable medicines… $1,920,342
Amendment Phase 1 clinical trial for therapeutic intervention particles (tips).this modification:1. Extends the POP by 12 months. Technical and financial reporting… -$1,920,342
Amendment Phase 1 clinical trial for therapeutic intervention particles (tips) add incremental funding to fully fund the award 1. Per section 711 of the national… $0
Original award $4,499,999

Quick answers

Who received award W81XWH2110875?

W81XWH2110875 was awarded to Institute For Evolvable Medicines by Defense Health Agency (Department of Defense) on September 30, 2021.

How much is award W81XWH2110875 worth?

$4,499,999 has been obligated on W81XWH2110875.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award